Eye disease treatment study using medical records
Part of Eyes & vision clinical trials.
This study uses a computer system to look at medical records of people who have had a certain type of eye injection. It aims to improve how information about eye treatments is shared and understood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a specific type of eye injection (OPS code 5-156.9) where medicine is injected into the back part of your eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop or solution (IRX-101) to see if it is safe and tolerable when given before or after your regular eye injections for conditions like wet macular degeneration. The goal is to find a way to make these injections more comfortable or safer.
This trial tests whether specially trained nurses can safely give eye injections instead of doctors. It may make treatment quicker and easier for people who need regular injections for eye conditions.
This trial tests a new eye injection (GenSci148) for people with wet age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. The injection may help reduce swelling and abnormal blood vessel growth in the retina, which can improve or stabilise vision.
This study looks at how eye pressure changes right after an eye injection. It aims to help doctors better understand and manage pressure spikes after treatment.
This is an early-stage safety study testing a new medicine injected directly into the eye to treat diabetic retinopathy (damage to blood vessels in the retina caused by diabetes). The study checks if the medicine is safe and how the body processes it.
This study looks at how repeated eye injections of a drug called bevacizumab affect chemicals in your blood that relate to heart health and inflammation. Researchers want to understand if these eye injections might impact your cardiovascular risk.
Hear when a new Intravitreal Injections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.